Stay updated with breaking news from Diagnostics Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Global Markets by Assay, by Cause, by Product, by Lab, and by Place. With Executive
ResMed Inc (ASX:RMD) and these ASX healthcare shares have been named as buys by Goldman Sachs. Here's why it is bullish...
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current...
/PRNewswire/ -- The "Sepsis Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed...
The sepsis diagnostics market size is projected to reach $1,226.52 million by 2028 from $661.83 million in 2021; it is expected to grow at a CAGR of 9.2%...